109 related articles for article (PubMed ID: 2011045)
1. Radioiodinated D-(+)-N1-ethyl-2-iodolysergic acid diethylamide: a ligand for in vitro and in vivo studies of serotonin receptors.
Lever JR; Scheffel UA; Musachio JL; Stathis M; Wagner HN
Life Sci; 1991; 48(15):PL73-8. PubMed ID: 2011045
[TBL] [Abstract][Full Text] [Related]
2. Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.
Wong DF; Lever JR; Hartig PR; Dannals RF; Villemagne V; Hoffman BJ; Wilson AA; Ravert HT; Links JM; Scheffel U
Synapse; 1987; 1(5):393-8. PubMed ID: 2905532
[TBL] [Abstract][Full Text] [Related]
3. N1-methyl-2-125I-lysergic acid diethylamide, a preferred ligand for in vitro and in vivo characterization of serotonin receptors.
Hoffman BJ; Scheffel U; Lever JR; Karpa MD; Hartig PR
J Neurochem; 1987 Jan; 48(1):115-24. PubMed ID: 3794694
[TBL] [Abstract][Full Text] [Related]
4. Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors.
Scheffel U; Lever JR; Stathis M; Ricaurte GA
Neuropharmacology; 1992 Sep; 31(9):881-93. PubMed ID: 1359444
[TBL] [Abstract][Full Text] [Related]
5. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
6. In vivo binding of 125I-LSD to serotonin 5-HT2 receptors in mouse brain.
Hartig PR; Scheffel U; Frost JJ; Wagner HN
Life Sci; 1985 Aug; 37(7):657-64. PubMed ID: 3160905
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vivo characterization of D-(+)-(N1-[11C]methyl)-2-Br-LSD: a radioligand for positron emission tomographic studies of serotonin 5-HT2 receptors.
Lever JR; Dannals RF; Wilson AA; Ravert HT; Scheffel U; Hoffman BJ; Hartig PR; Wong DF; Wagner HN
Int J Rad Appl Instrum B; 1989; 16(7):697-704. PubMed ID: 2575605
[TBL] [Abstract][Full Text] [Related]
8. Serotonergic and adrenergic regulation of skeletal muscle metabolism in the rat. II. The use of [125I]iodolysergic acid diethylamide and [125I]iodopindolol as probes of sarcolemmal receptor function and specificity.
Moretti-Rojas I; Ezrailson EG; Birnbaumer L; Entman ML; Garber AJ
J Biol Chem; 1983 Oct; 258(20):12499-508. PubMed ID: 6313663
[TBL] [Abstract][Full Text] [Related]
9. N1-methyl-2-[125I]LSD ([125I]MIL), a preferred ligand for serotonin 5-HT2 receptors.
Hoffman BJ; Karpa MD; Lever JR; Hartig PR
Eur J Pharmacol; 1985 Mar; 110(1):147-8. PubMed ID: 4007051
[No Abstract] [Full Text] [Related]
10. Autoradiographic localization and characterization of [125I]lysergic acid diethylamide binding to serotonin receptors in Aplysia.
Kadan MJ; Hartig PR
Neuroscience; 1988 Mar; 24(3):1089-102. PubMed ID: 3380298
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 125I-lysergic acid diethylamide binding to serotonin receptors in rat frontal cortex.
Kadan MJ; Krohn AM; Evans MJ; Waltz RL; Hartig PR
J Neurochem; 1984 Sep; 43(3):601-6. PubMed ID: 6747625
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors.
Lever JR; Scheffel UA; Stathis M; Musachio JL; Wagner HN
Life Sci; 1990; 46(26):1967-76. PubMed ID: 2362552
[TBL] [Abstract][Full Text] [Related]
13. Chronic imipramine treatment reduces (+)2-[125I]iodolysergic acid, diethylamide but not 125I-neuropeptide Y binding in layer IV of rat cerebral cortex.
Cummins JT; von Euler G; Fuxe K; Ogren SO; Agnati LF
Neurosci Lett; 1987 Mar; 75(2):152-6. PubMed ID: 3574772
[TBL] [Abstract][Full Text] [Related]
14. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
Peroutka SJ; Snyder SH
Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
[TBL] [Abstract][Full Text] [Related]
15. Comparison of [125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue.
Elliott JM; Kent A
J Neurochem; 1989 Jul; 53(1):191-6. PubMed ID: 2723656
[TBL] [Abstract][Full Text] [Related]
16. Localization and characterization by quantitative autoradiography of [125I]LSD binding sites in rat brain.
Nakada MT; Wieczorek CM; Rainbow TC
Neurosci Lett; 1984 Aug; 49(1-2):13-8. PubMed ID: 6493586
[TBL] [Abstract][Full Text] [Related]
17. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.
Buckholtz NS; Zhou DF; Freedman DX; Potter WZ
Neuropsychopharmacology; 1990 Apr; 3(2):137-48. PubMed ID: 1969270
[TBL] [Abstract][Full Text] [Related]
18. Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex.
Blue ME; Yagaloff KA; Mamounas LA; Hartig PR; Molliver ME
Brain Res; 1988 Jun; 453(1-2):315-28. PubMed ID: 3401769
[TBL] [Abstract][Full Text] [Related]
19. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
[TBL] [Abstract][Full Text] [Related]
20. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
Bischoff S; Heinrich M; Sonntag JM; Krauss J
Eur J Pharmacol; 1986 Oct; 129(3):367-70. PubMed ID: 3536532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
